Spyre Therapeutics, Inc.
SYRENASDAQHealthcare● Active
$71.54
$-2.11(-2.86%)
Market Cap$4.3B
P/E Ratio—
52W High$78.8
52W Low$13.93
Spyre Therapeutics, Inc.（SYRE）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SYRE · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.02B |
| Cost of Revenue | $0.17B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.17B) | $0.00B | $0.00B | $0.00B | $0.02B |
| Gross Margin %(computed) | — | — | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $0.17B | $0.16B | $0.09B | $0.06B | $0.06B |
| G&A Expenses | $0.05B | $0.05B | $0.04B | $0.03B | $0.03B |
| Total Operating Expenses | $0.04B | $0.21B | $0.24B | $0.09B | $0.08B |
| Operating Income | ($0.21B) | ($0.21B) | ($0.24B) | ($0.08B) | ($0.07B) |
| Operating Margin %(computed) | — | — | — | — | -350.33% |
| Interest Income | $0.02B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.16B) | ($0.21B) | ($0.34B) | ($0.08B) | ($0.07B) |
| Income Tax Expense | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) | $0.00B |
| Net Income | ($0.16B) | ($0.21B) | ($0.34B) | ($0.08B) | ($0.07B) |
| Net Margin %(computed) | — | — | — | — | -351.14% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.98 | $-3.18 | $-46.15 | $-24.86 | $-25.02 |
| Wtd Avg Shares | 0.35B | 0.05B | 0.01B | 0.00B | 0.00B |
| EBITDA | ($0.21B) | ($0.21B) | ($0.13B) | ($0.08B) | ($0.06B) |
| EBITDA Margin %(computed) | — | — | — | — | -341.92% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Spyre Therapeutics, Inc.
关于Spyre Therapeutics, Inc.（SYRE）损益表
Spyre Therapeutics, Inc.（SYRE）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，SYRE实现营收$0.00B，毛利润($0.17B)（毛利率—），净利润($0.16B)（净利率—）。
常见问题
SYRE · 4 问Spyre Therapeutics, Inc.（SYRE）2025财年营收为$0.00B，同比down—%。
SYRE revenueSYRE salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08